What’s New With RSV, COVID-19, and Flu Shots for Kids
Stanford Childrens
OCTOBER 16, 2023
As children are back in school and the days get chillier, it’s a reminder to protect our families against viruses this upcoming season. Palivizumab is approved for children under 24 months of age with certain conditions that place them at high risk for severe RSV disease. This must be given once a month during RSV season.
Let's personalize your content